+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Self-Expanding Stents - Global Stategic Business Report

  • PDF Icon

    Report

  • 64 Pages
  • April 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6069797
The global market for Self-Expanding Stents was estimated at US$3.8 Billion in 2024 and is projected to reach US$4.5 Billion by 2030, growing at a CAGR of 3.0% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Self-Expanding Stents market.

Global Self-Expanding Stents Market - Key Trends & Drivers Summarized

Why Is The Demand For Self-Expanding Stents Growing In Cardiovascular And Peripheral Procedures?

Self-expanding stents have become a cornerstone in interventional cardiology and vascular procedures due to their ability to improve blood flow in patients with narrowed or blocked arteries. Unlike balloon-expandable stents, which require external pressure to open, self-expanding stents expand automatically upon deployment, offering greater flexibility and adaptability to vessel movement. The rising prevalence of cardiovascular diseases (CVDs), including coronary artery disease (CAD) and peripheral artery disease (PAD), is fueling the need for advanced stent technologies. Additionally, the increasing number of minimally invasive procedures is driving demand for self-expanding stents, as they reduce recovery time, lower complication risks, and improve long-term patient outcomes.

What Technological Innovations Are Enhancing The Effectiveness Of Self-Expanding Stents?

Advancements in biomaterials and drug-eluting coatings are significantly improving the performance and safety of self-expanding stents. Nitinol (nickel-titanium alloy) stents are becoming the preferred choice due to their superelasticity and resistance to deformation. Drug-eluting stents (DES), which release antiproliferative drugs, are reducing the risk of restenosis (re-narrowing of arteries), ensuring long-term patency. Additionally, bioresorbable stents, which gradually dissolve in the body after healing the artery, are emerging as a promising alternative to permanent implants. Robotic-assisted stent placement and AI-powered imaging are enhancing precision in stent deployment, improving clinical success rates.

Which Healthcare Sectors Are Driving The Demand For Self-Expanding Stents?

Hospitals and cardiac catheterization labs are the primary end-users of self-expanding stents, as they are widely used in angioplasty procedures. Ambulatory surgical centers (ASCs) are also witnessing increased adoption of self-expanding stents due to the shift toward outpatient cardiovascular interventions. The geriatric population, which is at higher risk for vascular diseases, is contributing to the growing demand for stent-based treatments. Additionally, advancements in reimbursement policies and healthcare infrastructure in emerging markets are making self-expanding stent procedures more accessible.

What Factors Are Fueling The Growth Of The Self-Expanding Stents Market?

The growth in the self-expanding stents market is driven by the increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive procedures, and continuous innovation in stent materials and drug coatings. Regulatory approvals for next-generation stents and expanded healthcare access in developing regions are further boosting market expansion. Additionally, growing awareness of preventive cardiology and advancements in imaging technologies are enhancing patient screening and early intervention. As the demand for safer and more effective vascular treatments continues to rise, the self-expanding stents market is poised for sustained growth.

Report Scope

The report analyzes the Self-Expanding Stents market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments: Product Type (Carotid Self-Expanding Stents, Gastrointestinal Self-Expanding Stents, Endovascular Self-Expandable Stents, Others); Application (Fem-Pop Artery, Iliac Artery, Carotid Artery, Biliary, Others); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Carotid Self-Expanding Stents segment, which is expected to reach US$2.1 Billion by 2030 with a CAGR of a 2.9%. The Gastrointestinal Self-Expanding Stents segment is also set to grow at 2.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $989.1 Million in 2024, and China, forecasted to grow at an impressive 3.0% CAGR to reach $728.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Self-Expanding Stents Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Self-Expanding Stents Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Self-Expanding Stents Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott Laboratories, Alvimedica, amg International GmbH, Andramed GmbH, Balton Sp. z o.o. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 34 Featured):

  • Abbott Laboratories
  • Alvimedica
  • amg International GmbH
  • Andramed GmbH
  • Balton Sp. z o.o.
  • Becton, Dickinson and Company (BD)
  • Biosensors International Group, Ltd.
  • Biotronik
  • Boston Scientific Corporation
  • Cook Medical
  • Cordis
  • Elixir Medical Corporation
  • Endologix LLC
  • Eucatech AG
  • Hexacath
  • InspireMD
  • Jotec GmbH
  • Lifetech Scientific Corporation
  • Medinol Ltd.
  • Medtronic
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Optimed Medizinische Instrumente GmbH
  • Rontis Corporation
  • Sahajanand Medical Technologies
  • Stryker Corporation
  • Terumo Corporation
  • Translumina GmbH
  • Vesalio
  • W. L. Gore & Associates

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

  • Tariff-adjusted market forecasts by region and segment
  • Analysis of cost and supply chain implications by sourcing and trade exposure
  • Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

  • Finalized tariff impacts and new trade agreement effects
  • Updated projections reflecting global sourcing and cost shifts
  • Expanded country-specific coverage across the industry

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Alvimedica
  • amg International GmbH
  • Andramed GmbH
  • Balton Sp. z o.o.
  • Becton, Dickinson and Company (BD)
  • Biosensors International Group, Ltd.
  • Biotronik
  • Boston Scientific Corporation
  • Cook Medical
  • Cordis
  • Elixir Medical Corporation
  • Endologix LLC
  • Eucatech AG
  • Hexacath
  • InspireMD
  • Jotec GmbH
  • Lifetech Scientific Corporation
  • Medinol Ltd.
  • Medtronic
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Optimed Medizinische Instrumente GmbH
  • Rontis Corporation
  • Sahajanand Medical Technologies
  • Stryker Corporation
  • Terumo Corporation
  • Translumina GmbH
  • Vesalio
  • W. L. Gore & Associates

Table Information